Skip to main content

Advertisement

Log in

Cytomegaloviral enterocolitis

Clinical associations and outcome

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: Cytomegaloviral enterocolitis is an uncommon disorder that can complicate inflammatory bowel disease. It is more common in patients with acquired immunodeficiency syndrome and can occur in patients on immunosuppressive therapy for autoimmune or inflammatory diseases and in allograft recipients. Mortality rates of up to 71 percent have been reported for cytomegaloviral enterocolitis. The aims of this study were 1) to identify the presentation, underlying medical conditions, treatment, and outcome of patients with cytomegaloviral enterocolitis and 2) to determine the prevalence of this infection in patients undergoing intestinal resection for inflammatory bowel disease. METHODS: A retrospective chart review of patients with pathologic evidence of cytomegaloviral enterocolitis from 1985 through 1996 was performed. To determine the prevalence of this condition, the hospital discharge database was searched for the diagnoses of ulcerative colitis and Crohn's disease in patients who underwent bowel resection. RESULTS: 93 patients (mean age, 44 years; 66 percent males) had cytomegaloviral infection in the small intestine (n=6), large intestine (n=86), or appendix (n=1). Patients with acquired immunodeficiency syndrome (n=42), with ulcerative colitis (n=11), with Crohn's disease (n=11), receiving organ transplant (n=12), receiving bone marrow transplant (n=8), and in other immunosuppressed states (n=11) comprised this study. Seventeen patients (18 percent) underwent intestinal resection, and the remaining 76 patients were treated medically. Abdominal pain (77vs. 37 percent;P<0.01) and gastrointestinal bleeding (65vs. 34 percent;P<0.05) were more common presenting symptoms in patients who required resection than patients in the medically managed group. Mortality was 17.6 percent in the surgically managed group and 14.5 percent in the patients who were managed medically. The median duration of ulcerative colitis in patients with coexisting cytomegaloviral infection was 12 months. The prevalence of cytomegaloviral enterocolitis was 4.6 percent in patients with ulcerative colitis and 0.8 percent in patients with Crohn's disease. CONCLUSIONS: These data suggest that cytomegaloviral infection more frequently complicates ulcerative colitis than Crohn's disease. Furthermore, a short and fulminant course of ulcerative colitis may indicate coexisting cytomegaloviral infection. The overall low mortality in this retrospective study suggests that aggressive medical and surgical treatment improves survival in patients with cytomegaloviral enterocolitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shinozaki M, Masaki T, Muto T. Cytomegalic colitis after total colectomy in ulcerative colitis: report of a case. Dis Colon Rectum 1997;40:1124–7.

    Article  PubMed  Google Scholar 

  2. Loftus Jr EV, Alexander GL, Carpenter HA. Cytomegalovirus as an exacerbating factor in ulcerative colitis. J Clin Gastroenterol 1994;19:306–9.

    PubMed  Google Scholar 

  3. Berk T, Gordon SJ, Choi HY, Cooper HS. Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol 1985;80:355–60.

    Google Scholar 

  4. Orvar K, Murray J, Carmen G, Conklin J. Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci 1993;38:2307–10.

    Article  PubMed  Google Scholar 

  5. Powell RD, Warner NE, Levine RS, Kirsner JB. Cytomegalic inclusion disease and ulcerative colitis: report of a case in a young adult. Am J Med 1961;30:334–40.

    Article  PubMed  Google Scholar 

  6. Wong HW, Warner NE. Cytomegalic inclusion disease in adults. Arch Pathol 1962;74:403–22.

    PubMed  Google Scholar 

  7. Keren DF, Milligan FD, Strandberg JD, Yardley JH. Intercurrent cytomegalovirus colitis in a patient with ulcerative colitis. Johns Hopkins Med J 1975;136:178–82.

    PubMed  Google Scholar 

  8. Cooper HS, Raffensperger EC, Jonas L, Fitts WJ. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology 1977;72:1253–6.

    PubMed  Google Scholar 

  9. Sidi S, Graham JH, Razvi SA, Banks PA. Cytomegalovirus infection of the colon associated with ulcerative colitis. Arch Surg 1979;114:857–9.

    PubMed  Google Scholar 

  10. Eyre-Brook IA, Dundas S. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut 1986;27:1419–25.

    PubMed  Google Scholar 

  11. Patel R, Snydman DR, Rubin RH,et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996;61:1279–89.

    Article  PubMed  Google Scholar 

  12. Hibberd PL, Snydman DR. Cytomegalovirus infection in organ transplant recipients. Infect Dis Clin North Am 1995;9:863–77.

    PubMed  Google Scholar 

  13. Zaia JA, Forman SJ. Cytomegalovirus infection in the bone marrow transplant recipient. Infect Dis Clin North Am 1995;9:879–900.

    PubMed  Google Scholar 

  14. Kram HB, Shoemaker WC. Intestinal perforation due to cytomegalovirus infection in patients with AIDS. Dis Colon Rectum 1990;33:1037–40.

    Article  PubMed  Google Scholar 

  15. Wexner SD, Smithy WB, Trillo C, Hopkins BS, Dailey TH. Emergency colectomy for cytomegalovirus ileocolitis in patients with the acquired immune deficiency syndrome. Dis Colon Rectum 1988;31:755–61.

    PubMed  Google Scholar 

  16. Stein H, Slek SD. The incidence of infection with cytomegalovirus in a normal population: A serologic study in greater London. J Hyg 1965;63:79–87.

    Google Scholar 

  17. Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA. Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 1997;50:59–63.

    PubMed  Google Scholar 

  18. d'Arminio Monforte A, Mainini F, Testa L,et al. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS 1997;11:517–24.

    PubMed  Google Scholar 

  19. Anonymous. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch Intern Med 1995;155:65–74.

  20. Gane E, Saliba F, Valdecasas GJ,et al. Randomised trial of efficacy and saftety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. Lancet 1997;35:1729–33.

    Article  Google Scholar 

  21. Page MJ, Dreese JC, Poritz LS, Koltun WA. Cytomegalovirus enteritis: a highly lethal condition requiring early detection and intervention. Dis Colon Rectum 1998;41:619–23.

    PubMed  Google Scholar 

  22. Van Dorp WT, Jonges E, Bruggeman CA, DaHa MR, VanEs LA, Van der Wonde EJ. Direct induction of MHC class I but not class II expression of endothelial cells by cytomegalovirus infection. Transplantation 1989;48:469–72.

    PubMed  Google Scholar 

  23. Iwamoto GK, Monick MM, Clark BD, Auron PE, Stinski MF, Hunninhake GW. Modulation of interleukin 1 beta gene expression by three immediate early genes of human cytomegalovirus. J Clin Invest 1990;85:1853–7.

    PubMed  Google Scholar 

  24. Soderlund C, Bratt GA, Engstrom L,et al. Surgical treatment of cytomegalovirus enterocolitis in severe human immunodeficiency virus infection: report of eight cases. Dis Colon Rectum 1994;37:63–72.

    Article  PubMed  Google Scholar 

  25. Rich JD, Crawford JM, Kazanjian PH. Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: Report of three cases and review. Clin Infect Dis 1992;15:609–14.

    PubMed  Google Scholar 

  26. Evans JD, Robertson CS, Clague MB, Snow MH, Booth H. Severe lower gastrointestinal haemorrhage from cytomegalovirus ulceration of the terminal ileum in a patient with AIDS. Eur J Surg 1993;159:373–5.

    PubMed  Google Scholar 

  27. Ho M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc 1994;26(Suppl 1):7–11.

    Google Scholar 

  28. Bowden RA, Sayers M, Flornooy N,et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006–10.

    PubMed  Google Scholar 

  29. Winston DJ, Ho WG, Lin C-H,et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987;106:12–8.

    PubMed  Google Scholar 

  30. Sullivan KM, Kopecky KJ, Jocom J,et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990;323:705–12.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Read at the meeting of The American Society of Colon and Rectal Surgeons, San Antonio, Texas, May 2 to 7, 1998.

About this article

Cite this article

Kaufman, H.S., Kahn, A.C., Iacobuzio-Donahue, C. et al. Cytomegaloviral enterocolitis. Dis Colon Rectum 42, 24–30 (1999). https://doi.org/10.1007/BF02235178

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02235178

Key words

Navigation